Proteomics Analysis of Human Tears in the Diagnosis and Management of Dry Eye Disease

NARecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Dry Eye Disease (DED)Dry Eye
Interventions
DEVICE

The Rexon-Eye, an electrotherapy device utilizing Quantum Molecular Resonance (QMR) technology

The device has received EC certification as a medical device for the treatment of ocular surface disorders. It will deliver a low-intensity alternating electrical current (ranging from 4 MHz to 64 MHz) to targeted biological tissue via contact electrodes. Previous studies have shown the effectiveness of this treatment in alleviating dry eye symptoms, both subjectively and objectively.

Trial Locations (1)

Unknown

RECRUITING

The Hong Kong Polytechnic University, Hong Kong,, Hong Kong

All Listed Sponsors
lead

The Hong Kong Polytechnic University

OTHER